Inhibition of both c-Met and EGFR signaling shows synergistic antitumor activity in non-small cell lung cancer model

被引：1
|
作者：
Tammam, Jennifer G.
Davis, Lenora
Ware, Chris
Reilly, John F.
Deshmukh, Sujal V.
Dinsmore, Christopher
Marshall, Gary
Harrington, Elizabeth A.
Pan, Bo-Sheng
Lutterbach, Bart A.
Majumder, Pradip K.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C209
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
    Fong, Jason T.
    Jacobs, Ryan J.
    Moravec, David N.
    Uppada, Srijayaprakash B.
    Botting, Gregory M.
    Nlend, Marie
    Puri, Neelu
    PLOS ONE, 2013, 8 (11):
  • [12] Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status
    Bloom, K. J.
    Ha, T.
    Uyeda, L.
    Choppa, P.
    MODERN PATHOLOGY, 2012, 25 : 473A - 473A
  • [13] Evaluation of c-Met FISH on Non-Small Cell Lung Cancer Samples with Known EGFR Mutational Status
    Bloom, K. J.
    Uyeda, L.
    Choppa, P.
    LABORATORY INVESTIGATION, 2012, 92 : 473A - 473A
  • [14] INTEGRIN BETA1 MEDIATES EGFR TKI RESISTANCE THROUGH C-MET SIGNALING PATHWAY IN NON-SMALL CELL LUNG CANCER
    Ju, L.
    Zhou, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 76 - 76
  • [15] Antitumor Activity of a Bispecific Chimera Targeting EGFR and Met in Gefitinib-Resistant Non-Small Cell Lung Cancer
    Wang, Ya
    Zhang, Guixi
    Zhou, Zhilan
    Zhang, Ning
    Jiang, Hang
    Liu, Yichang
    Fu, Ting
    Zhu, Yingdi
    Li, Juan
    ADVANCED HEALTHCARE MATERIALS, 2025, 14 (02)
  • [16] C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
    Tsakonas, G.
    Hirsch, F. R.
    Ekman, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2124 - S2125
  • [17] c-MET as a biomarker in patients with surgically resected non-small cell lung cancer
    Tsakonas, Georgios
    Botling, Johan
    Micke, Patrick
    Rivard, Chris
    LaFleur, Linnea
    Mattsson, Johanna
    Boyle, Teresa
    Hirsch, Fred R.
    Ekman, Simon
    LUNG CANCER, 2019, 133 : 69 - 74
  • [18] The role of HGF/C-met signalling pathway on the non-small cell lung cancer
    Gumustekin, M.
    Sis, B.
    Bulut, G.
    Kargi, A.
    Oztop, I.
    Olgun, N.
    Atabey, N.
    FEBS JOURNAL, 2006, 273 : 89 - 89
  • [19] PROTEASOME INHIBITORS REDUCE C-MET IN NON-SMALL CELL LUNG CANCER CELLS
    Li, Yanhui
    Dong, Su
    Tamaskar, Arya
    Wang, Heather
    Zhao, Jing
    Zhao, Yutong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (05) : 1117 - 1118
  • [20] HGF/c-Met Overexpressions, but not Met Mutation, Correlates with Progression of Non-small Cell Lung Cancer
    Gumustekin, Mukaddes
    Kargi, Aydanur
    Bulut, Gulay
    Gozukizil, Aysim
    Ulukus, Cagnur
    Oztop, Ilhan
    Atabey, Nese
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 209 - 218
12345